Connect with us


What Will Be the Contours of the Biden Administration’s Global Health Agenda?




Key Points

  • The Biden administration brings a starkly different vision for U.S. international engagement, including global health, compared to the “America First” foreign policy doctrine of its predecessor.
  • At the top of the agenda is addressing COVID-19, re-engaging with the global community more broadly, and pursuing a stepped-up emphasis on global health security.
  • The administration has already taken several actions including: releasing a National Strategy on COVID-19 and Pandemic Preparedness; issuing a National Security Memorandum and Executive Order on U.S. global leadership on COVID-19 and global health security; restoring funding for and membership in WHO; joining COVAX; and rescinding the Mexico City Policy. It has also proposed several other actions, including some that require Congressional support.
  • Yet the extent to which the administration will seek to champion core global health programs beyond COVID-19 and preparedness remains unknown, as does the level of support from Congress, given the pressures of COVID-19 and economic strain at home. The stakes are even higher now, given the emergence of new COVID-19 variants and the slow roll-out of vaccines.
  • Among the many key policy issues and outstanding questions ahead are the following:
    • How the U.S. will be received on the global stage;
    • How best to balance COVID-19 needs at home and abroad;
    • How robust will U.S. support for global COVID-19 vaccine access be;
    • Whether global health security will become a dominant frame for U.S. global health engagement;
    • How much room there will be to address the unfinished business of global health, including the effects of COVID-19 on core programs;
    • The balance between bilateral and multilateral U.S. health investments;
    • How the U.S. will approach WHO reform;
    • How far will the administration go in its support for global family planning and reproductive health and how will it withstand partisan push back in Congress; and
    • Whether the bipartisan consensus regarding global health funding can be maintained.


On January 20, President Biden took the oath of office, in the midst of a pandemic that is raging out of control across the U.S. and throughout the world. Biden brings a starkly different vision for U.S. international engagement, including global health, compared to the “America First” foreign policy doctrine of his predecessor. At the top of the Biden administration’s agenda is addressing the COVID-19 pandemic at home and abroad, re-engaging with the global community more broadly, and pursuing a stepped-up emphasis on global health security. The administration has also signaled more general support for U.S. global health programs. In the first days of office, the Biden administration has already put into place policies, strategies, and staff with expertise in these areas and has indicated that more actions are to come. Some of the proposed actions can be taken via executive authority while others will require the cooperation and approval of Congress. While Congress has provided emergency support for global COVID-19 relief, including for health, and demonstrated some appetite for bolstering U.S. global health security, it is unclear how the new administration’s proposals will fare given broader partisan gridlock and the strains on the U.S. economy. In addition, the extent to which the Biden administration will seek to champion core U.S. global health programs, or change the broader U.S. global health architecture, beyond an expanded focus on global health security, remains unclear. It’s also possible that even maintaining support for the current U.S. global health portfolio could be difficult, given the extreme domestic pressures related to COVID-19. With this as the backdrop, we provide an overview of the Biden administration’s COVID-19 and global health actions to date, as well as likely ones on the horizon, and identify key policy issues and outstanding questions ahead. The stakes are particularly high, given the emergence of variants of SARS-CoV-2, the virus that causes COVID-19, that appear to spread more easily and the slow roll-out of vaccines.

The Biden Administration’s Global Health Agenda

Both on the campaign trail and during his first days of office, Biden has made it clear that he seeks to re-embrace international engagement, including on health, with COVID-19 as a top focus. Biden has made re-embracing the global community a key policy goal for his administration. This represents a major departure from the Trump administration’s posture, which saw the U.S. sit out the international response to COVID-19, withdraw from the Paris Climate Accord, and withhold funding for the World Health Organization (WHO), while initiating the process of withdrawing from WHO membership. By contrast, the Biden administration has critiqued this approach, stating that “America’s withdrawal from the international arena has impeded progress on a global COVID-19 response and left the United States more vulnerable to future pandemics. U.S. international engagement to combat COVID-19, promote health, and advance global health security will save lives, promote economic recovery, and build better resilience against future biological catastrophes.” The new administration has already taken several actions on this front, including issuing a National Strategy for the COVID-19 Response and Pandemic Preparedness; a National Security Memorandum on “United States Global Leadership to Strengthen the International COVID-19 Response and to Advance Global Health Security and Biological Preparedness”; and an Executive Order on “Organizing and Mobilizing the United States Government to Provide a Unified and Effective Response to Combat COVID-19 and to Provide United States Leadership on Global Health and Security”. It has also proposed several other actions, some of which are dependent on Congressional support (see Table). Given the widespread nature and ever-evolving threat from COVID-19, including the rise of variants that may spread more easily, it appears likely that addressing the pandemic and its many effects will occupy much of the global health policy attention within the administration for the foreseeable future.

Among the new administration’s first actions was announcing that the U.S. would remain a WHO member and continue funding the organization. Just as the COVID-19 pandemic was devasting much of the world, including the U.S., Trump announced last April that he was putting a hold on U.S. funding to WHO, pending investigation of its COVID-19 response, and formally notified the United Nations in July of last year that the U.S. would withdraw from WHO membership (effective one-year later per U.S. law). Historically, the U.S. had been the largest funder of the WHO, providing $400 million to $500 million in funding to the organization each year, and had played a leadership role in the organization. Withholding funds and initiating a process to withdraw from the world’s international health organization had both practical and symbolic effects. Biden campaigned on retracting the Trump administration’s decision and restoring funding, actions taken on day one of the Biden administration. This included formal communication with the United Nations and WHO about the U.S. intent to remain a member of WHO and continue funding; a call by the Vice President to the WHO Director General; and, as specified in the National Security Memorandum on COVID-19 and global health security, intent to work with the WHO to strengthen and reform the organization to enhance its ability to respond to COVID-19, global health, and future pandemics, a goal shared by other Member States.

The administration also announced that the U.S. would support the Access to COVID-19 Tools (ACT) Accelerator and join the COVAX Facility and commit to multilateralism and the international COVID-19 response. These actions were announced on January 21, 2021, and directed by the President in the National Security Memorandum, as part of the new administration’s package of COVID-19 policies. By contrast, under the Trump administration, the U.S. had been one of the only countries not to formally participate in the ACT Accelerator or COVAX, or the broader international response. While Congress had provided emergency funding to Gavi in support of COVID-19 vaccine access in low- and middle- income countries, the absence of U.S. leadership in these initiatives under the Trump administration marked a break from how the U.S. responded to most other recent global health emergencies. The Biden administration also said it would develop a framework for donating surplus vaccines, once there is sufficient supply in the U.S., to countries in need, including through COVAX. The Trump administration had included similar language in a December 2020 Executive Order, which was largely focused on ensuring American access to vaccines. In addition, the Biden administration has said it would seek funding from Congress to strengthen and sustain other multilateral initiatives involved in addressing COVID-19, including the Coalition for Epidemic Preparedness Innovations (CEPI); Gavi; and the Global Fund to Fight AIDS, TB and Malaria (Global Fund). Notably, the plan for a stepped-up U.S. international COVID-19 response explicitly includes an emphasis on “reducing racial and ethnic disparities and seeing to the needs of marginalized and indigenous communities, women and girls, and other groups.” Finally, the new administration announced it was re-entering the Paris Climate Agreement, as part of its major commitment to address climate change which it sees as a driver of health threats.

In addition, marking a significant break from the prior four years, the Biden administration has rescinded the Mexico City Policy and seek to restore funding for UNFPA, and has said it would recommit to addressing sexual and reproductive health and rights.  First announced in 1984 by the Reagan administration, the Mexico City Policy (called “Protecting Life in Global Health Assistance” by the Trump administration) has been rescinded and reinstated by subsequent administrations along party lines, having been in effect for 21 of the past 36 years. The policy requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning” using funds from any source (including non-U.S. funds) as a condition of receiving U.S. government global family planning assistance and, under the Trump administration, most other U.S. global health assistance. This marked an unprecedented expansion of the policy. On January 28, President Biden issued a Presidential Memorandum announcing that he was rescinding the policy, effective immediately, and it would no longer be applied to existing awards or any future ones. In addition, the Memorandum also announced that the administration would take the necessary steps to restore funding to UNFPA. The Trump administration had withheld Congressionally-appropriated funding from UNFPA for four years, by invoking the Kemp-Kasten amendment. In rescinding the Mexico City Policy and moving to restore UNFPA funding, the Biden administration stated that it was U.S. policy “to support women’s and girls’ sexual and reproductive health and rights in the United States, as well as globally,” and also announced that it would withdraw from the Geneva Consensus Declaration, an October 2020 statement crafted and signed by the U.S. and 32 other countries, meant to enshrine the former administration’s values and principles related to women’s health, abortion in particular, and family, in the international sphere. Collectively, these actions signify a significant turn from the Trump administration’s approach which had sought to impose restrictions, limit funding, and alter international and bilateral agreements to reflect these views.

As part of his COVID-19 “American Rescue” plan, Biden has said he would seek $11 billion for global COVID-19 efforts. The American Rescue Plan includes $11 billion to support “the international health and humanitarian response; mitigate the pandemic’s devastating impact on global health, food security, and gender-based violence; support international efforts to develop and distribute medical countermeasures for COVID-19; and build the capacity required to fight COVID-19, its variants, and emerging biological threats.” To date, through prior COVID-19 relief bills, Congress has provided approximately $7.5 billion to overall global COVID-19 efforts. Of this, $5.2 billion has been allocated for global health, primarily for vaccine support ($4 billion); to date, no funding has been provided to address the primary or secondary impacts of the pandemic on existing global health programs. At this time. only limited detail on the administration’s $11 billion request is available and it is unclear if it will garner enough support from members of Congress.

Action Requires Administrative or
Congressional Action?
Restore the National Security Council’s Directorate for Global Health Security and Biodefense Administrative
Rescind the Mexico City Policy Administrative
Restore funding to UNFPA Administrative
Release a National COVID-19 Response Strategy, including a strategy for international engagement Administrative
Restore funding to WHO and reverse Trump administration decision to withdraw from WHO membership Administrative
Support the ACT-Accelerator and Join COVAX Administrative/


Create position of Coordinator of the COVID-19 Response and Counselor, reporting to the President Administrative
Develop a diplomatic outreach plan led by the State Department to enhance the US response to COVID-19, including through the provision of support to the most vulnerable communities. Administrative**
Provide $11 billion to support “international health and humanitarian response,” including efforts to distribute countermeasures for COVID-19, build capacity required to fight COVID-19, and emerging biological threats Congressional Proposed
Ensure adequate, sustained U.S. funding for global health security Congressional Proposed
Expand U.S. diplomacy on global health and pandemic response, including elevating U.S. support for the Global Health Security Agenda (GHSA) Administrative Proposed
Call for the creation of permanent international catalytic financing mechanism for global health security and work with international financial institutions, including multilateral development banks, to promote support for combating COVID-19 and strengthening global health security Administrative Proposed
Call for creation of a Permanent Facilitator within the Office of the United Nations Secretary-General for Response to High Consequence Biological Events Administrative Proposed
*Depending on the details of the administration’s proposal to support the ACT-Accelerator and join COVAX, Congressional approval may be required.
**The National Security Memorandum requires the Secretary of State, in consultation with the Secretary of HHS, the Representative of the United States to the United Nations, the Administrator of USAID, and the Director of the CDC, to develop this plan within 14 days or as soon as possible.

The administration has also begun to institute a new structure for the White House and National Security Council (NSC) Staff, including re-establishing the NSC Directorate on Global Health Security and Biodefense. By all indications, Biden and his transition team see global health, especially as it relates to the pandemic, as an integral part of their foreign policy agenda. He re-established, via Executive Order, the NSC Directorate on Global Health Security and Biodefense (originally created during the Obama administration and charged with overseeing pandemic response but shuttered by the Trump administration in 2018), and named a COVID-19 Coordinator to oversee a whole of government approach to pandemic response. Further, Biden has already appointed or nominated advisors and key staff with experience in global health and infectious disease threats and/or a strong belief in the importance of international engagement, including his Chief of Staff (Ron Klain); Chief Medical Advisor (Tony Fauci); Secretary of State (Anthony Blinken); National Security Advisor (Jake Sullivan); NSC Senior Director for Global Health Security and Biodefense (Beth Cameron); CDC Director (Rochelle Walensky); USAID Administrator (Samantha Power); and the President’s Malaria Coordinator (Raj Panjabi). Biden will now look to nominate or appoint persons to fill other critical U.S. global health positions including the U.S. Global AIDS Coordinator, the Department of Health and Human Services’ Director of the Office of Global Affairs, and USAID’s Assistant Administrator for Global Health.

Indeed, scaling up the U.S. global health security effort and apparatus is shaping up to be a signature global health focus of the Biden agenda, one which already has some bipartisan support in Congress. In the administration’s National COVID-19 strategy and elsewhere, Biden and key staff have discussed the need for significant changes in the level and scope of U.S. support for global health security programs to reduce the chances of repeating our current pandemic crisis in the future. This includes the Executive Order on “Organizing and Mobilizing the United States Government to Provide a Unified and Effective Response to Combat COVID-19 and to Provide United States Leadership on Global Health and Security” and National Security Memorandum on “United States Global Leadership to Strengthen the International COVID-19 Response and to Advance Global Health Security and Biological Preparedness. Global health security programs, which help countries build their capacities to prevent, detect, and respond to emerging disease outbreaks, have long been supported by the U.S. government and were maintained during the Trump administration, but have suffered from limited and sporadic funding and bouts of attention only during times of crisis. COVID-19 has precipitated urgent attention to this area that is likely to result in greatly expanded U.S. ambitions, with key Biden staff outlining such a vision for months and referencing public health as a permanent U.S. national security priority that will be an initial and major focus for the administration. There has also been some Congressional support for doing more, including a bipartisan proposal released last year from Senators Risch, Murphy, and Cardin to enhance strategic planning, strengthen interagency coordination, and grow U.S. diplomatic presence in global health security efforts.

Figure 1: U.S. Global Health Funding, FY 2006 – FY 2021

The administration has expressed support for other core U.S. global health efforts, including PEPFAR, but it is not yet known how prominently they will figure into its agenda or how they will be connected to the broader global health security push; at the same time, there remains much unfinished business in improving the health of those in low-and middle-income countries. The U.S. is the largest funder of global health efforts in the world, operating programs in more than 70 countries; 80% of its funding is provided through bilateral programs and the remainder through multilateral efforts. These programs (including PEPFAR and the Global Fund) have not only been credited with saving millions of lives, they have been shown to contribute to global health security efforts, including during the 2014 Ebola outbreak in West Africa. Yet U.S. funding for global health has largely been stagnant for years, despite the unfinished business that remains (although Trump sought significant and unprecedented cuts each year in office, these were rejected time and again by Congress). Within the U.S. global health portfolio, PEPFAR represents the largest component, and one which has been credited with saving millions of lives. During his time as a Senator and Vice President, Biden supported U.S. global health programs broadly, including as a sponsor of PEPFAR’s first re-authorization and as recently as last month saying he would work to expand support for PEPFAR. As mentioned above, the administration has said it would seek more funding for the Global Fund and Gavi, given their direct role in responding to the pandemic, and seek to mitigate the secondary impacts of COVID-19 and strengthen bilateral U.S. programs in HIV, TB, malaria, and other health systems strengthening efforts. Biden’s strategy notes that in addition to the immediate response needs the pandemic is a moment the U.S. has an opportunity to “reset and drive action to advance the Sustainable Development Goals, make gains toward achieving Universal Health Coverage.”  But it is not yet clear if and to what extent the administration will seek to increase funding for, or make fundamental changes to, the core U.S. bilateral global health programs, or seek to shift the balance of its investments between bilateral and multilateral support to perhaps move toward these bolder, broader goals. Given that PEPFAR is largest component of the U.S. global health response and is primed for an update to its goals and direction, Biden’s choice to fill the U.S. Global AIDS Coordinator position and his first global health budget request will be especially significant and offer an indication of his vision for addressing HIV globally while also signaling his approach to broader U.S. global health engagement.

Key Questions Ahead

The global health agenda and overall approach to international engagement espoused by the Biden administration is a clear break from the four year “America First” approach under Trump. It also marks a potential departure from prior administrations, given its heavy focus on global health security in light of the devastation caused by the COVID-19 pandemic, a focus which could have lasting effects on the U.S. approach to global health. Whether or not Biden will be able to achieve the broad goals he has outlined is uncertain, and there are likely to be checks on his ambitions. It is also unclear how existing global health programs supported by the U.S. will figure into these plans. Among key questions to consider are the following:

  1. How will the U.S. be received on the global stage? As the U.S. seeks to re-engage globally, how will the international community respond, especially given the changing and in some cases more prominent roles played by others, including China and the European Union? Is there a unique window of opportunity for the Biden administration to use its diplomatic power to rally countries and institutions in support of the global COVID-19 response, particularly around vaccines? Will vaccine aid become a new version of soft power? Or has the dynamic of U.S. leadership permanently shifted, given the retreat during the Trump years, and the ongoing challenges of battling COVID-19 at home? Will the circumstances of a post-COVID world require a new way for the U.S. to engage internationally on global health issues, or will relations revert back to the pre-COVID state of affairs?
  2. How best to balance COVID-19 needs at home and abroad? Despite the fact that the COVID-19 pandemic has thrown into stark relief the interconnectedness of the world, the U.S. remains in the throes of a domestic health and economic crisis. There may emerge competition – for both resources and vaccine supply – between domestic and global needs. How much recognition will there be that U.S. safety is inextricably linked to success in addressing the global pandemic? Can a broader, global response be pursued by the Biden administration in this context? Will it face push back by Congress or a public that still awaits a return to some sense of normalcy?
  3. How robustly will the administration support global COVID-19 vaccine access, including COVAX? Given that vaccinating as many people as possible around the world is the surest way to bring the pandemic under control, ensuring access to vaccines will be pivotal for U.S. progress on many domestic and international policy priorities. The U.S. has now stated an intention to join COVAX, but under what terms? Will it join as a self-financing country and purchase vaccines itself through this mechanism, and/or support the COVAX Advance Market Commitment in support of low- and middle- income country access? Exactly when and how will the U.S. government approach donating excess doses, through COVAX or otherwise? Given that successful vaccination programs rely not just on doses and supplies but also workers, PPE, and other capabilities, will support for delivery and health systems more broadly also be incorporated into the U.S. response?
  4. Will global health security become a dominant frame for U.S. global health engagement going forward? U.S. global health programs address a broad array of health challenges – from HIV, to maternal and child mortality, to neglected tropical diseases and many more. Will contributions to preparedness and security become the overarching paradigm for thinking and talking about U.S. global health programs? If so, will this help to strengthen existing global health programs or create unintended consequences that could hinder their efforts? How might the U.S. define the focus and the scope of its health security approach? And, can the administration work with Congress to bring an end to the boom and bust cycles for global health security with longer-term commitments and predictable funding? Or, will this be once again forgotten when the world is able to move past COVID-19?
  5. What about the unfinished business of global health? Is there room – beyond COVID-19 and global health security – to expand U.S. global health efforts and how aggressively will the new administration seek to do so? Given the enormity of COVID-19 it is understandable the Biden administration’s immediate focus is on the pandemic and global health security, but what will happen to the broader U.S. global health agenda? Will there be room to set ambitious new goals for core U.S. global health programs? Will the new administration double down in these core areas as part of a push to shore up global health security? With COVID-19 exposing the weaknesses of health systems and preparedness around the world, will there be a reexamination of the balance of U.S. global health support between vertical, disease-focused programs and broader, health systems strengthening? If so, what risks could this pose and how can the contribution of these programs to health systems strengthening and global health security be better measures, captured, and built upon? And, how can the new administration address the impacts of COVID-19 on existing U.S. supported health programs, as well as its secondary effects on the health and economies of low-and middle-income countries? To date, for example, none of the core U.S. global health programs (beyond global health security) have received any supplemental support to address the impacts of and setbacks due to COVID-19.
  6. What is the right balance between bilateral and multilateral U.S. health investments, both for COVID-19 and global health more broadly? How should the administration’s $11 billion global COVID-19 relief request be channeled between its own programs and international response mechanisms? What about core U.S. global health investments, which have been impacted by COVID-19 but not yet received any emergency support? Are there ways to better coordinate between bilateral and multilateral health efforts, particularly PEPFAR and the Global Fund, to create greater impact? As the Global Fund and GAVI increasingly phase-down and end their support for middle income countries, what is the role of the U.S. government in helping to meet the needs of those living in these countries who continue to face access barriers and suffer adverse health outcomes? How will COVID-19 change these considerations?
  7. What will be the administration’s approach to reforming WHO and other international institutions? 2021 will mark the beginning of a process to reckon with the weaknesses in international and domestic systems that were laid bare by the COVID-19 pandemic. How much will the administration push, for example, for significant change to multilateral institutions such as WHO or support attempts to revamp existing international health agreements such as the International Health Regulations? How will the tension between the U.S. and China, that played out so clearly in the pandemic, affect diplomacy around WHO reform?
  8. How far will the administration go in its support for global family planning and reproductive health and how will it withstand partisan push back in Congress? How forceful will the new administration be on this front? Given that family planning and reproductive health is still likely be subject to fierce partisan battles in Congress, how will the new administration navigate and address these tensions? Can the U.S. move past the constant log-jam and ping pong nature of the Mexico City Policy?
  9. Finally, how will the administration grapple with the reality of having only the slimmest of Democratic majorities in the Senate in seeking to achieve its COVID-19 and global health agenda? Undergirding much of a Biden agenda on COVID-19 and global health will be the need to maintain bipartisan, Congressional support. Will the bipartisan consensus that has characterized much of U.S. global health prevail, or will there be a turn toward austerity and pressure to cut foreign aid? Will exceptions be made for the global COVID-19 response? How can the Biden administration navigate support for global health across the aisle as it seeks an expansion domestic agenda? (as we’ve seen in the past during periods of economic distress and rising deficits)?



AllStar Health Brands Announces Updates on Covid Testing Initiatives




Miami, FL, April 2, 2021 – OTC PR WIRE — AllStar Health Brands Inc. (OTC Pink: ALST) (“AllStar Health” or the “Company”), a specialty pharmaceutical and nutritional supplements company, is pleased to update current and prospective shareholders on the status of the Company’s ON-Going Business Operations including Covid-19 testing Initiatives in several countries.

“As a Distributor for TPT Medtech, we are continuing to work in other countries including South Africa with the goal of introducing the ‘QuikPASS’ and ‘QuikLAB’ systems to offer definitive testing solutions in these countries,” stated Dr. Bagi, CEO of AllStar.

AllStar is a Distribution partner for TPT MedTech products and services in Jamaica. BayWest Wellness Center in Jamaica has contracted with TPT MedTech to utilize its “QuikPASS” and Check & Verify Passport technology systems at the Montego Bay Airport to verify that individuals have been tested to leave the county of Jamaica.  Baywest Wellness secured the Covid 19 testing contract with the Montego Bay Airport in February 2021 and executed its technology deal with TPT MedTech in February as well.

About AllStar Health Brands

AllStar Health Brands Inc. is a Nevada Corporation established in 2017, and headquartered in Miami, Florida. AllStar is a specialty HealthCare Products Company dedicated to improving health and quality of life by offering select, nutritional supplements, over the counter remedies, and medicines all across the Americas and Europe. AllStar’s goal is to bring additional products to the market and provide new, innovative options for better health and wellbeing.

For more information, please contact Investor Relations at (305) 423 7028.

Safe Harbor Statement

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.

The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management, as well as assumptions made by any information currently available to the Company or its management. When used in this document, the words “anticipate,” “estimate,” “expect,” “intend,” “plans,” “projects,” and similar expressions, as they relate to the Company or its management, are intended to identify forward-looking statements. Such statements reflect the current view of the Company regarding future events and are subject to certain risks, uncertainties, and assumptions, including the risks and uncertainties noted. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove to be incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated, expected, intended or projected. In each instance, forward-looking information should be considered in light of the accompanying meaningful cautionary statements herein. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, the impact of competitive services and pricing and general economic risks and uncertainties.

SOURCE: AllStar Health Brands Inc.

Public Relations
EDM Media, LLC
(800) 301-7883

Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading


Enerkon Solar International (ENKS) Names New Board and Scientific Committee Members and Announces New FARA Filing in support of Commercial Aspirations




New York, April 1, 2021 – OTC PR WIRE – Enerkon Solar International (OTC PINK: ENKS) Names New Board and Scientific Committee Members and Announces today New FARA Filing in support of Commercial Aspirations in North Africa and other Important Updates regarding the new SARS2-COVID 15 Second “Insta-Test”.

ENKS Chairman Mr. Ballout stated that since the company Nominated a New Scientific Committee and Board Members this week, the company issue the first name selections today which are:

  • Senator Roberto Lario Rodriguez (Ret.) – (El Salvador) Advisory Bord Member for South and Central America
  • Dr Ibrahim El Nattar – (Egypt) Advisory Board Member for Renewable Energy in Africa
  • Dr Mark Schutz – Bioscience – (MD 0- USA), Graphene and Passive Immunity and Medical Advisory Board member
  • Michael Vishmidt (Israel/Ukraine) – Scientific Advisory Board Member for New Technology and Research
  • Dr Vasily Muraveynik, (Ukraine) – New Biomedical Science Advisory Board Member
  • Isaac Ray (Cal. USA) Special Scientific Advisor for Industrial Emission Suppression Technology
  • Nural KARAVELİOĞLU – (Turkey) – Consulting Board Member for Renewable Energy, Hydrogen and Government Relations”
  • Omar Mabruk Ilhayam (UK) – Advisory Board Member on Commerce and Energy for North Africa (Libya – Egypt – Algeria – Morocco – Tunisia) supporting Solar – Hydrogen – Energy Industry new Technology Transfer / Commercialization

Mr. Ballout Commented: “Our Great New Scientific and Regional Advisory Board will enhance Shareholder Value through supporting growth and expansion of ENKS and its Diverse Holdings – CVs and other information will be posted on the company website this week as well as other information on new opportunities and expansion plans.”

ENKS is comprised of 6 (Since the Sale of East Africa Unit to AL Fada Equity Holdings Last week)  -Companies, including corporate wholly or majority owned divisions – Corporate information for each will be posted on the company website for ease of search as some shareholders or investors have mentioned it was difficult to locate some of the data online, causing the possibility for others posting wrong or misleading information online –  therefore the company shall post additional legal documents and status information on line for all to have access”

Mr. Ballout Stated: “The company is proud of its New commercial relationship with companies and government personalities in Libya and Today, we have added an additional Statement of Registration with the US DOJ FARA National Security Division Agency for our work with the new, UNSMIL backed Government of Libya – This in support of our Compliance requirements for disclosure and in furtherance of our commercial aspirations in North Africa, related to Renewable Solar Energy, Hydrogen and other Commercial Interaction with the Region and in pre opposition to any Fake news, state clearly that the company has NO signed contracts with the government yet while we are hopeful that we will in the near future either via commercial entities or PPP structures we have for North Africa”.

“A technical call remains scheduled, with the new ChNPP director regarding the Chernobyl Special Exclusion Zone technical points and contents of this call which will be video recorded will explain better to the general public what Solar,  Co-Generation is (the use of Solar Power (about 500 MW or less to Power Electric Steam Boilers which in turn are planned to supply the pressure needed to drive the 3 Turbine Electric generators on the ChNPP Site whereby each generator has a tolerance of nearly 1 Gigawatt – and further auxiliary power from the solar array will power a 50 and later a 100MW Electrolysis Driven Green Hydrogen Plant to supply buyers of Green Hydrogen. The company, has already received expression of interest letters from German, Green Hydrogen Buyers and we shall post these letter(s) on the company website in coming days as well.”

Additional Support for the Modernization of the Ukraine Metals industry, will entail plans for Titanium Production and mining modernization – and Carbon Anode Sourcing for their Aluminum Industry – including Graphite Electrodes for their  Steel Industry modernization plans in the future (a letter from the Vice Prime minister of Ukraine regarding our cooperation on the Titanium Industry has already been received by the company some weeks ago – expressing appreciation and explaining the many jobs and social benefits of such cooperation to future development in Ukraine.

ENKS will Name a New Auditor Next Week once the File is Opened and Started for our last two years and current year Audit – in addition it is noted that this Auditor shall be retained on a continuous basis for all quarterly and Annual Reports in support of compliance requirements upon our planned up listing – this information will be added to the OTC Disclosures Site Page under Professional Service Providers (Auditor).

NEWS: Regarding the SARS2-COVID 15 Second “Insta-Test” device already produced for clinical trials and approvals (Owned by Graphene Leaders Canada and Distributed by KrowdX who has co sales agreements with the Coviklear International Holdings (UK) Unit Purchased before last week.

Mr. Ballout Stated:“ Great strides have been made in the development of the project supporting the commercialization of the SARS2-COVID Graphene Nanotech Based – 15 second “Insta-Test” – this being owned by GLC Canada and Distributed by KrowdX of Montreal – We are pleased to update that Pre Orders are due in very soon from ENKS /Coviklear partners abroad for the benefit of Krowdx and GLC to fulfill upon and after FDA Approval which is expected very soon (within just weeks as clinical trials of the already produced pre-production device is near completion during the next 10 days or so. – The Market for this device to Governments world wide cannot be understated, as it is the fastest test so far in the world and uses a much superior testing system, which takes only 15 seconds maximum time and uses a novel nanotech graphene biosensor to accomplish the amazing feat so fast, with such accuracy, (estimated at more than 97+ Percent) – Covillear Parent company  – ENKS also is in final talks with DGI in New York, for Financial Support to guarantee order fulfillment – supply chain management and other administrative support where needed, if asked to help, by the Owners and Distributors – This being our expression of confidence, as while we have already spent $5 Million USD to purchase Coviklear in a Debt Equity Swap before last week we are ready to engage much greater amounts of capital from our third party financial resources to support Factoring Order Fulfillment – Purchase order finance and other tools that may support the commercialization world wide for this groundbreaking disruptive Technology. It is noted that this is NOT a PCR test, and it does NOT use Reagents, or any chemicals whatsoever, its is based on electrical impedance using Nano Tech Graphene substrate, to send analysis to the device output at a very fast and high rate of efficacy – being far superior to PCR and similar tests, including all other DNS/RNA Tests – The test is NON-Invasive and safe.”

GLC Medical Inc. – Insta Test Initial Version

GLC Medical Inc. – Insta Test Updated Version

Governments and related PPPs / NGOs and others have expressed serious and immediate interest in ordering this new device which is now a reality, minus only its EUA (Emergency Use Application Green light at the FDA/HC and WHO) and this includes the KrowdX proprietary SES and STS solution for Airports – Sea Ports, Land Borders and other access and entry points between cities states provinces and otherwise to regain control of the Pandemic and free the world´s population again.

These details will be released by the Distributor KrowdX /Covikear, as they mutually agree, in the coming days/Week(s).

“Needless to say, the market value for this new device and technology is absolutely enormous, subject only to the contingencies mentioned above and we are absolutely excited about it all.”

“Stay Tuned for more updates on all of these new developments during the coming days and week(s)”


The Company expect to name an Auditor as previously mentioned above, during late next week if all goes well, in the company cost and – time – to – completion negotiations, going on now.

“Loyal ENKS Shareholders, are the ‘ENKS ARMY’, and the company will always support their best interests working to enhance shareholder value and steady growth.”

The foregoing statements are forward looking statements, and as such, they may or may not reflect the results which could transpire in the future which should be negative or not transpire at all due to circumstances or other reasons and investors, shareholders, or others should not rely on these forward-looking statements to ascertain any value if any of ENKS or to make any investment decisions and to take note that this is not an offer to buy or sell securities or an endorsement of ENKS for investment purposes as all investment carry a risk of loss sometimes a total loss of your investment in Micro cap shares markets or any market and therefore such statements or plans should not be relied upon for any business decisions of any kind – Approval and permissions required by federal regulations may or may not be approved and if not approved may result in the loss of all value and all investments in products requiring such regulatory permissions to market and sell. These statements are made as forward-looking statements for educational purposes only in accordance with the rules and regulations which pertain to the same.

Enerkon Solar International Inc.

New HQ Address in New York at:

Enerkon Solar International Inc

477 Madison Avenue

New York, NY 10022 USA

Tel. +1 (877) 573-7797

Tel. +1 (718) 709-7889

Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading


Qtum Partners with Vaccine Forward to Boost Global COVID-19 Vaccination Efforts


The blockchain platform Qtum has announced the partnership with Vaccine Forward to help the fundraising initiative to raise vaccines for distribution to over 92 countries. The goal of the partnership is to raise $2 billion to speed the vaccination process through some of the world’s poorest countries, with the Qtum Chain Foundation committing to match […]

The post Qtum Partners with Vaccine Forward to Boost Global COVID-19 Vaccination Efforts appeared first on Blockonomi.




The blockchain platform Qtum has announced the partnership with Vaccine Forward to help the fundraising initiative to raise vaccines for distribution to over 92 countries.

The goal of the partnership is to raise $2 billion to speed the vaccination process through some of the world’s poorest countries, with the Qtum Chain Foundation committing to match the total number of vaccines raised by Vaccine Forward.

Vaccine Forward is a Swedish-based initiative aiming to fight this inequality having raised over 12k vaccinations ever since its start and has now looked for the support of the blockchain and crypto industry in collaboration with Qtum Chain Foundation, which has provided half of the total vaccinations.

Elisabeth Thand Ringqvist, Vaccine Forward founder, referred to the partnership by stating:

“As a grass-roots organization, Vaccine Forward is proud to receive the biggest donation so far, effectively doubling the amount of raised vaccinations, from 6 000 to 12 000 with Qtum’s donation. We are also very happy for Qtum’s challenge to the Blockchain-space at large to do the same.”

The organization depends on private and corporate donations to make it possible to help countries who need the vaccines to ensure the health of their citizens, which are distributed via the Global Vaccine Alliance (GAVI).

Soon, donors will also be able to contribute to this mission by making donations using cryptocurrency directly on Vaccine Forward’s website, facilitating the process for people around the world who might not be able to donate with fiat otherwise.

Crypto As a Tool for Equality

While developed countries have moved forward with vaccination efforts, countries with poor economies and strong political relationships have struggled to vaccinate their citizens, creating a high level of inequality among a pandemic that affects all countries equally.

One of the pillars of the crypto movement on its inception and till this day has been to provide people around the world with access to financial services and platforms without the need for centralized authorities having power over them, which has made crypto a lifeline for residents of countries under extreme poverty, dictatorships, or economic sanctions.

Cryptocurrency has been used by organizations like AirTm to help citizens from countries like Venezuela to receive economic assistance from people abroad by bypassing legal sanctions and economic restrictions placed by their country and foreign governments, highlighting some of the benefits of decentralization.

Similarly, projects designed to allow charities to receive donations from interested parties have also become increasingly popular in the crypto ecosystem, which has proven to be invaluable for charities over the last years.

Qtum Co-Founder, Jordan Earl, referred to the potential the industry has to help the transition out o the pandemic by saying:

“We hope that we can inspire our industry to do the same and also match Vaccine Forwards fundraising to help in the effort of vaccinating people who need it the most. We at Qtum are global problem solvers with an open platform and therefore, I think the grass-roots organization Vaccine Forward is an amazing solution to a complex global problem.”

The Qtum Ecosystem Continues to Grow

Qtum has experienced increasing success over the past year, which has not only been reflected by its cryptocurrency’s gain in value but also by the expansion of its ecosystem.

The most recent news came in the form of an announcement of its commitment to provide Filecoin with smart contracts capabilities through the Qtum network, something that while not only benefits users of the platform but also Qtum itself as part of its portfolio controls about 10% of Filecoin’s mining power.

Great Options for New Markets

Qtum is also looking into launching NFT support to compete against networks like Ethereum by offering lower prices, which has been an increasing pain for projects running on the Ethereum network.

With major networks like Cardano, Polkadot, and Ethereum getting closer to the release of their next updates, Qtum is looking forward to becoming a major competitor in the growing crypto ecosystem.

The network’s coin, QTUM, has gained over 700% in value over the last year according to Coingecko data, with a 90% over the last month which has seen most of the big projects in the crypto market go through a bearish trend.


Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading


France Imposes 3rd National Lockdown As COVID-19 Again Surges




Young people gathered Wednesday by the Seine River in Paris, largely without masks and without social distancing. French President Emmanuel Macron has ordered the country into a third lockdown because of the continued spread of COVID-19. Eleanor Beardsley/NPR hide caption

toggle caption

Eleanor Beardsley/NPR

PARIS – Calling the new, faster-spreading variants of the coronavirus “an epidemic within the epidemic,” French President Emmanuel Macron on Wednesday extended a lockdown to the entire country and closed schools through the end of April.

In a televised address to the nation, Macron said a “more dangerous, contagious and deadly” virus surging in France left him no choice.

“If we are choosing to close down the whole country it’s because no area of the country is spared,” Macron said. “Everywhere the virus is spreading faster and faster and everywhere, hospitalizations are rising.”

Gatherings inside and outside are also banned and people will not be allowed to travel more than 10 kilometers (6.2 miles) from their homes. Macron said unlike the first confinement last spring, people who leave their homes will not have to fill out a form with the time, date and purpose of their outing. “We are choosing to have confidence in people’s sense of responsibility,” he said.

“Everyone has to make sure not that they close themselves in, but that they limit, to the maximum, their contacts, meetings and time spent with others,” said Macron.

The president’s announcement was entirely anticipated. France’s intensive care units are at capacity with more than 5,000 COVID-19 patients health officials say, and hospitalizations have already surpassed the second wave of this past winter. They are on track to surpass even the first deadly wave of last spring.

Over the weekend, several dozen emergency room doctors signed an open letter in the newspaper Le Journal du Dimanche, warning that if something is not done, hospitals would soon have to begin choosing which patients receive treatment. “We cannot remain silent without betraying our Hippocratic oath,” they said.

Jacob Kirkegaard, who studies health care systems as a senior fellow with the German Marshall Fund, says the new strains of the virus are forcing countries to step up their public health measures. Britain, Germany and Italy are also in various forms of lockdown.

“When COVID cases in a country are suddenly much more contagious, the lockdowns need to be adjusted and made much tougher,” he said.

Kirkegaard said vaccinations in France have not yet increased to a level which would make a difference in transmission. Thirteen percent of the French have received one dose of a vaccine. Only 4% have been fully vaccinated. But Macron said the pace of vaccination would go faster very soon.

“We are putting all our means behind vaccinating, vaccinating, vaccinating,” he said, “on Saturday and Sunday just like during the week.” Macron said some 250,000 health professionals – doctors, pharmacists, veterinarians and fire fighters – will be involved in the massive vaccination effort across the country.

Over the last few warm, spring days, the banks of the Seine River in Paris have looked a lot like Venice Beach, Calif., with young people working-out and sunbathing, their masks under their chins. Macron said there will be patrols enforcing restrictions on alcohol consumption in public and plenty of fines given. Bars and restaurants have been closed since last fall.

Doctors say COVID-19 patients in France’s ICUs are younger and younger, often without any underlying health problems. Macron said 44% of patients in intensive care are younger than 65.

The country’s Scientific Council, which advises the government on measures to combat the virus, called for a strict lockdown in January. Macron defended his decision not to lock the country down then, saying people had benefitted from “precious weeks of liberty.”

But he said the accelerating pandemic propelled by new variants meant France had to set a new course for the coming months.

Writing of the gravity of the situation this week in the newspaper Libération, Patrick Bouet, president of the National Council of the Order of Doctors, called on Macron to institute stricter measures. “The virus is winning and we have lost control of the pandemic,” Bouet said.

France is now approaching 100,000 coronavirus deaths. “That’s the equivalent of wiping the city of Nancy from the map,” wrote Bouet.

Coinsmart. Beste Bitcoin-Börse in Europa

Continue Reading
Esports4 days ago

Dota 2 Patch 7.29 Will Reveal a New Hero

Esports4 days ago

Best Warzone guns: the weapons you need to use in Black Ops Cold War Season 2

Fintech3 days ago

Novatti’s Ripple partnership live to The Philippines

Fintech5 days ago

Standard Chartered turbocharges digital payments proposition with investment and the merger of CurrencyFair with Assembly Payments

Blockchain4 days ago

Evil Geniuses Partner With Cryptocurrency Exchange Platform Coinbase

Blockchain5 days ago

Unternehmen gründen Crypto Council: Fidelity und Coinbase mit dabei

Esports5 days ago

Overwatch Archives event 2021: new challenges, skins, and more

Cyber Security4 days ago

Fintechs are ransomware targets. Here are 9 ways to prevent it.

Blockchain5 days ago

Bitcoin Preis Update: BTC fällt unter 59.500 USD

Esports4 days ago

indiefoxx was just banned from Twitch again, but why?

Blockchain4 days ago

Krypto-News Roundup 8. April

Blockchain5 days ago

Ripple Klage: CEO zeigt sich nach Anhörung positiv

Blockchain4 days ago

DFB bringt digitale Sammelkarten auf die Blockchain

Esports2 days ago

Dota 2 Dawnbreaker Hero Guide

Esports5 days ago

Astralis vs Gambit Esports: ESL Pro League betting analysis

Esports2 days ago

Dallas Empire escape with a win against Minnesota at the Stage 2 Major

Blockchain5 days ago

Krypto News Roundup 7. April 2021

Blockchain4 days ago

WEF-Gipfel 2021: Zukunft der Wirtschaft ist tokenisiert

Fintech3 days ago

TrueLayer raises US$70m to build the world’s most valuable Open Banking network

Esports1 day ago

Why did Twitch ban the word “obese” from its predictions?